Hillhouse Investment — Full Portfolio
5 tracked investments · listed companies and verified rows first
Axoft is developing soft, tissue-mimicking neural implants and supporting bidirectional electronics that record and stimulate brain activity through a minimally-invasive burr-hole procedure.
AI & Machine LearningDeep TechMedical DevicesCambridge, US
Paul Le Floch(Executive Officer, Director)inTianyang Ye(Director)inRachel Sha(Director)
BoardChia An Lee(Director)Benjamin Pless(Director)
Co-investorsArcherman CapitalBlindspot Ventures Management CoCastor Ventures (an Alumni Ventures Fund)Creative Destruction Lab (CDL)Safar PartnersThe Engine Ventures+2 more
Hystar develops PEM electrolysers for hydrogen production, using a patented design that combines fuel cell industry technology with electrolyser technology for higher efficiency and safety.
CleantechEnergyHardware
Co-investorsAP VenturesFinindusFirdaTrustbridge Partners
Hystar is a Norwegian cleantech company that develops and manufactures high-efficiency PEM (Proton Exchange Membrane) electrolysers, which use renewable electricity and water to produce green hydrogen.
CleantechEnergyHardwareHøvik, NO
Co-investorsFirdaMOL SwitchAP VenturesFinindusNysnø Climate InvestmentsORLEN VC+1 more
Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.
BiotechMedical DevicesLower Gwynedd, US
Joseph Erhardt(Executive Officer)inPeter Lebowitz(Executive Officer, Director)
BoardArjun Goyal(Director)inOtello Stampacchia(Director)inFrancesco Draetta(Director)in
Co-investorsAndreessen HorowitzVida Venturesabrdn plcBiotechnology Value FundForesite CapitalOmega Funds+1 more
Dinii (株式会社ダイニー) uses technology to support Japan's restaurant and food-service industry, aiming to become essential infrastructure for both restaurant operators and consumers.
FoodTechRetail TechSaaSTokyo, JP
Mao Yamada(Founder)in
Co-investorsBessemer Venture PartnersCoral CapitalGlobis Capital PartnersEclecticFlight Deck Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.